139 related articles for article (PubMed ID: 3160413)
1. Impaired responsiveness to B cell growth factor in a patient with common variable hypogammaglobulinemia.
Perri RT; Weisdorf DJ
Blood; 1985 Aug; 66(2):345-9. PubMed ID: 3160413
[TBL] [Abstract][Full Text] [Related]
2. Severe T lymphocyte immunodeficiency associated with hypogammaglobulinemia: defective lymphokine secretion but enhanced autologous mixed lymphocyte reaction.
Raziuddin S; Teklu B
J Clin Immunol; 1989 Nov; 9(6):448-53. PubMed ID: 2576557
[TBL] [Abstract][Full Text] [Related]
3. Characterization of normal peripheral blood T- and B-cell colony-forming cells: growth factors(s) and accessory cell requirements for their in vitro proliferation.
Georgoulias V; Marion S; Consolini R; Jasmin C
Cell Immunol; 1985 Jan; 90(1):1-13. PubMed ID: 3871357
[TBL] [Abstract][Full Text] [Related]
4. Dissociation in the production of B cell-stimulating factors (BCGF and BCDF) and interleukin 2 by T cells from a common variable immunodeficient patient.
Saiki O; Shimizu M; Saeki Y; Kishimoto S; Kishimoto T
J Immunol; 1984 Oct; 133(4):1920-4. PubMed ID: 6088629
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the suppressor activity in lymphocytes from patients with common variable hypogammaglobulinemia: evidence for an associated primary B-cell defect.
Rodriguez MA; Bankhurst AD; Williams RC
Clin Immunol Immunopathol; 1983 Oct; 29(1):35-50. PubMed ID: 6309448
[TBL] [Abstract][Full Text] [Related]
6. Clonal analysis of B cell growth and differentiation activities induced from T lymphocytes upon triggering of T3-Ti and T11 pathways.
Milanese C; Bensussan A; Reinherz EL
J Immunol; 1985 Sep; 135(3):1884-90. PubMed ID: 3160783
[TBL] [Abstract][Full Text] [Related]
7. Defect in production of B cell differentiation factor-like activity by mononuclear cells from a boy with hypogammaglobulinemia.
Matheson DS; Green BJ
J Immunol; 1987 Apr; 138(8):2469-72. PubMed ID: 3494068
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of a B cell growth inhibitory factor (BIF) on BCGF-dependent B cell proliferation.
Kawano M; Iwato K; Kuramoto A
J Immunol; 1985 Jan; 134(1):375-81. PubMed ID: 3871108
[TBL] [Abstract][Full Text] [Related]
9. Regulation of B cell activation and differentiation with factors generated by human T cell hybridomas.
Mayer L; Fu SM; Kunkel HG
Immunol Rev; 1984 Apr; 78():119-35. PubMed ID: 6234220
[TBL] [Abstract][Full Text] [Related]
10. Role of DNA synthesis in secretion of immunoglobulin from murine B cells stimulated by T cell derived lymphokines.
Simpson LG; Isakson PC
J Immunol; 1986 Sep; 137(6):1797-802. PubMed ID: 3091690
[TBL] [Abstract][Full Text] [Related]
11. Impaired expression of cell surface receptors for B cell growth factor by chronic lymphocytic leukemia B cells.
Perri RT
Blood; 1986 Apr; 67(4):943-8. PubMed ID: 3485460
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-4 suppresses immunoglobulin production by peripheral blood lymphocytes of patients with common variable immunodeficiency (CVI) induced by supernatants of T cell clones.
Pastorelli G; Roncarolo MG; Touraine JL; Rousset F; Pene J; de Vries JE
Clin Exp Immunol; 1989 Dec; 78(3):341-7. PubMed ID: 2575470
[TBL] [Abstract][Full Text] [Related]
13. Activity of a partially purified human BCGF on murine assays for B cell stimulatory factors. II. Synergy between two distinct BCGF II-like factors in promoting B cell differentiation.
Ennist DL; Elkins KL; Cheng SC; Howard M
J Immunol; 1987 Sep; 139(5):1525-31. PubMed ID: 2957428
[TBL] [Abstract][Full Text] [Related]
14. Different reactivity of activated human B cells to B-cell growth factor and interleukin 2 in the costimulation assay with anti-IgM antibody and in the preactivation assay with Staphylococcus bacteria.
Almerigogna F; Biagiotti R; Giudizi GM; Del Prete GF; Maggi E; Mazzetti M; Alessi A; Ricci M; Romagnani S
Cell Immunol; 1985 Oct; 95(2):358-67. PubMed ID: 3876163
[TBL] [Abstract][Full Text] [Related]
15. B cell function in acquired "common-variable" hypogammaglobulinemia: proliferative responses to lymphokines.
Farrant J; Bryant A; Almandoz F; Spickett G; Evans SW; Webster AD
Clin Immunol Immunopathol; 1989 May; 51(2):196-204. PubMed ID: 2784752
[TBL] [Abstract][Full Text] [Related]
16. Augmentation of normal and malignant B cell proliferation by monoclonal antibody to the B cell-specific antigen BP50 (CDW40).
Ledbetter JA; Shu G; Gallagher M; Clark EA
J Immunol; 1987 Feb; 138(3):788-94. PubMed ID: 3492534
[TBL] [Abstract][Full Text] [Related]
17. Development of a human T-cell hybridoma secreting separate B-cell growth and differentiation factors.
Butler JL; Falkoff RJ; Fauci AS
Proc Natl Acad Sci U S A; 1984 Apr; 81(8):2475-8. PubMed ID: 6609362
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of a B cell activation factor (BCAF) produced by a human T cell line.
Bowen DL; Ambrus JL; Fauci AS
J Immunol; 1986 Mar; 136(6):2158-63. PubMed ID: 3485143
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies to the human C3b/C4b receptor (CR1) enhance specific B cell differentiation.
Weiss L; Delfraissy JF; Vazquez A; Wallon C; Galanaud P; Kazatchkine MD
J Immunol; 1987 May; 138(9):2988-93. PubMed ID: 2952731
[TBL] [Abstract][Full Text] [Related]
20. B cell growth factor activity of immunoaffinity-purified and recombinant human interleukin 2.
Mingari MC; Gerosa F; Moretta A; Zubler RH; Moretta L
Eur J Immunol; 1985 Feb; 15(2):193-6. PubMed ID: 3871701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
